6533b873fe1ef96bd12d4d15

RESEARCH PRODUCT

Role of CD1A and HSP60 in the antitumoral response of oesophageal cancer

Francesco CappelloGiampiero La RoccaGiovanni ZummoL MarasàSimona CorraoRita AnzaloneFelicia Farina

subject

Settore BIO/17 - Istologialcsh:Internal medicineCancer ResearchDiseasemedicine.disease_causeImmune systemAntigenmedicineNeoplasmlcsh:RC31-1245Settore BIO/16 - Anatomia Umanabusiness.industryCancerImmune response - Dendritic cells - Chaperonopathies - Chaperonotherapylcsh:Other systems of medicinemedicine.diseaselcsh:RZ201-999EpitheliumChaperonopathies Chaperonotherapy Dendritic cells Immune responsemedicine.anatomical_structureOncologyImmunologyCancer researchCarcinogenesisbusinessIntracellular

description

Oesophageal cancer (OC) is one of the most common and severe forms of tumor. A wider knowledge of molecular mechanisms which lead to a normal epithelium becoming a neoplasm may reveal new strategies to improve treatment and outcome of this disease. In this review, we report recent findings concerning molecular events which take place during carcinogenesis of the oesophagus. In particular, we focus on the role of two molecules, CD1a and Hsp60, which are overexpressed in oesophageal and many other types of tumor. Both molecules may present tumor antigens and promote in situ the stimulation of an antitumoral immune activity. We suggest there is a synergistic action between these molecules. Further knowledge about their intracellular pathways and extracellular roles may help develop new antitumoral tools for OC.

https://doi.org/10.4081/oncol.2007.225